Suma Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

Suma Krishnan is President, R&D of Krystal Biotech, Inc.. Currently has a direct ownership of 1.41 Million shares of KRYS, which is worth approximately $291 Million. The most recent transaction as insider was on Jan 03, 2023, when has been sold 1,700 shares (Common Stock) at a price of $80.33 per share, resulting in proceeds of $136,561. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.41M

1.74% 3M change

5.81% 12M change

Total Value Held $291 Million

Suma Krishnan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 03 2023	SELL Open market or private sale	$136,561 $80.33 p/Share	1,700 Reduced 0.1%	1,706,201 Common Stock
Dec 29 2022	SELL Open market or private sale	$646,568 $80.7 p/Share	8,012 Reduced 0.47%	1,707,901 Common Stock
Dec 16 2022	SELL Open market or private sale	$843,212 $80.1 p/Share	10,527 Reduced 0.61%	1,715,913 Common Stock
Nov 08 2022	SELL Open market or private sale	$65,872 $80.04 p/Share	823 Reduced 0.05%	1,726,440 Common Stock
Aug 05 2022	SELL Open market or private sale	$2,033,750 $81.35 p/Share	25,000 Reduced 1.43%	1,727,263 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$205,125 $62.5 p/Share	3,282 Reduced 0.19%	1,752,263 Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	-	28,400 Added 1.5%	1,864,464 Common Stock

Suma Krishnan

President, R&D

Pittsburgh, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Value

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Krystal Biotech, Inc.

Track Activities on KRYS

Account